tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY
Advertisement

Incyte (INCY) Similar Stocks

Compare
1,763 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$83.90
$16.24B
18.90
26.30%
8 Buy
8 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$53.94
$10.20B
15.74
-23.54%
20 Buy
4 Hold
0 Sell
Strong Buy
Exelixis
$39.14
$10.50B
18.71
41.81%
10 Buy
9 Hold
0 Sell
Moderate Buy
United Therapeutics
$397.97
$18.23B
15.74
15.35%
8 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$194.62
$11.79B
34.55%
16 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$27.99
$17.25B
13.86
6.85%
4 Buy
2 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
83.90
18.73
28.74%
BMRN
BioMarin Pharmaceutical
53.94
-17.20
-24.18%
EXEL
Exelixis
39.14
12.32
45.94%
UTHR
United Therapeutics
397.97
55.38
16.17%
ASND
Ascendis Pharma
197.24
48.36
32.48%
GMAB
Genmab
28.24
2.04
7.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis